• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 8, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Cancer drug stimulates tripolar mode of mitosis

Bioengineer by Bioengineer
September 12, 2017
in Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Helmholtz Zentrum München – German Research Center for Environmental Health) Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy. A current study has investigated the underlying mechanisms of this action – and which biomarkers may be useful for predicting the success of therapy. The study, published in the journal Oncogene, was carried out within the framework of the Clinical Cooperation Group Personalized Radiotherapy in Head and Neck Cancer at Helmholtz Zentrum München and Munich University Hospital.

Share12Tweet8Share2ShareShareShare2

Related Posts

Machine Learning Framework Assesses Roadway Vulnerability Using Aerial Imagery

Machine Learning Framework Assesses Roadway Vulnerability Using Aerial Imagery

September 8, 2026

Disitamab vedotin shows phase 3 benefit in HER2-positive breast cancer liver metastases

September 8, 2026

Risk factors for shunt conversion and brain bleeding after ventriculosubgaleal shunts

September 8, 2026

Glutamine pathway helps dormant prostate cancer cells survive and recur

September 8, 2026
Please login to join discussion

POPULAR NEWS

  • Machine Learning Framework Assesses Roadway Vulnerability Using Aerial Imagery

    29 shares
    Share 12 Tweet 7
  • Disitamab vedotin shows phase 3 benefit in HER2-positive breast cancer liver metastases

    29 shares
    Share 12 Tweet 7
  • Risk factors for shunt conversion and brain bleeding after ventriculosubgaleal shunts

    29 shares
    Share 12 Tweet 7
  • Glutamine pathway helps dormant prostate cancer cells survive and recur

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Machine Learning Framework Assesses Roadway Vulnerability Using Aerial Imagery

Disitamab vedotin shows phase 3 benefit in HER2-positive breast cancer liver metastases

Risk factors for shunt conversion and brain bleeding after ventriculosubgaleal shunts

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.